Background The purpose of this study was to explore a new estrogen receptor (ER) and/or
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …

Purpose To study the clinicopathological variables connected with disease-free survival
(DFS) as well as overall survival (OS) in patients who are ER-positive or HER2-negative and …

To determine 2 different prognostic indexes (PI) for the differentiation of subgroups of
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …

Introduction Prognostic prediction based on prognostic stage (PS) with the Oncotype DX
recurrence score (RS) has not been validated in stage III ER+/HER2− breast cancer. This …

Aim: To determine 2 different prognostic indexes (PI) for the differentiation of subgroups of
nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) …

Purpose Prediction algorithms estimating survival rates for breast cancer (BC) based upon
risk factors and treatment could give a help to the clinicians during multidisciplinary …

Purpose To assess the dynamic link between continuous estrogen receptor (ER) expression
and long-term clinical outcomes in non-metastatic breast cancer and to identify the ideal …

Aims Clinicians use multi-gene/biomarker prognostic tests and free online tools to optimize
treatment in early ER+/HER2− breast cancer. Here we report the comparison of recurrence …

Background Young age is regarded as an adverse prognostic factor in patients with breast
cancer, especially in those with a hormone receptor (HR)‐positive tumor. We investigated …

Purpose We aimed to develop a nomogram to predict prognosis of HR+ HER2-breast
cancer patients and guide the application of postoperative adjuvant chemotherapy. Methods …